Neurodegenerative Diseases: current treatment algorithm and potential investment opportunities covered in a lates research report

This report examines the entire neurodegenerative disease therapy area, with a particular focus on the three most prevalent neurodegenerative disorders: Alzheimer’s disease (AD), Parkinson’s disease (PD) and multiple sclerosis (MS).

Pune, India - March 14, 2018 /MarketersMedia/ —

AD and PD represent the most pressing challenges within the disease cluster, due to rapidly increasing prevalence driven by aging populations. Both AD and PD remain ineffectively treated despite substantial investment into R&D by pharmaceutical companies, due to high clinical trial failure rates. As a result there are no disease-modifying therapies for these two indications, with available treatments able to provide only marginal symptomatic relief. MS, the autoimmune disease of the CNS, contrasts with the rest of this cluster, as it affects a different population demographic, and has a lucrative pharmacological market following breakthrough success in the past decade.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-neurodegenerative-diseases-protein-misfolding-targets-and-neuromodulators-dominate-the-first-in-class-pipeline-and-lead-the-way-as-potential-disease-modifying-therapies-in-ad-and-pd
Reasons To Buy
• Appreciate the current clinical and commercial landscapes by considering disease symptoms, pathogenesis, etiology, co-morbidities and complications, epidemiology, diagnosis, prognosis and treatment options.
• Identify leading products and key unmet needs within the market.
• Recognize innovative pipeline trends by analyzing therapies by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using proprietary matrix assessments, first-in-class targets in the pipeline have been assessed and ranked according to clinical potential. Individual matrix assessments are provided for targets categorized into four major classes: protein misfolding, neuromodulators, immunomodulators and neuroprotectants. The most promising first-in-class targets are reviewed in greater detail.
• Consider first-in-class pipeline products with no prior involvement in licensing and co-development deals, which may represent potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/935553
Scope
• Unmet need is extremely high in AD and PD, with MS showing continued promise in the development of effective therapies
• What are the most important etiological risk factors and pathophysiological processes implicated in AD, PD and MS?
• What is the current treatment algorithm?
• How effective are current therapies for these indications, and how does this impact prognosis?
• The AD pipeline is large and contains a very high proportion of first-in-class product innovation.
• Which molecule types and molecular targets are most prominent across AD, PD and MS?
• What are the connections, in terms of first-in-class innovation, between AD, PD and MS?
• Which first-in-class targets are most promising?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935553

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/neurodegenerative-diseases-current-treatment-algorithm-and-potential-investment-opportunities-covered-in-a-lates-research-report/314330

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-neurodegenerative-diseases-protein-misfolding-targets-and-neuromodulators-dominate-the-first-in-class-pipeline-and-lead-the-way-as-potential-disease-modifying-therapies-in-ad-and-pd%20

Source: MarketersMedia

Release ID: 314330

Latest News

Chinese official: Beijing should target goods needed by US

Sep 19, 2018

BEIJING — One of China's most prominent figures in global finance says Beijing should press Washington to end their tariff battle by clamping down on exports of goods needed by American companies, according to news reports Monday. The comments by Lou Jiwei, a former finance minister and chairman of China's sovereign wealth fund, follow reports regulators are squeezing American companies by slowing down customs approvals and stepping up environmental and other inspections. Also Monday, an official newspaper called for more aggressive measures to "make American pain worse" following tariff hikes by both sides on $50 billion of each other's goods....

World stocks rise on report of US-China trade talks

Sep 19, 2018

SINGAPORE — Many global markets climbed Thursday following a report that the U.S. has proposed a new round of trade negotiations with China before going ahead with plans to slap tariffs on $200 billion or more in Chinese goods. Investors also appeared heartened by an interest rate increase by Turkey that could help ease its currency crisis, while other major central banks in Europe held off major policy changes. KEEPING SCORE: In Europe, France's CAC 40 gained 0.4 percent to 5,354 while the DAX in Germany added 0.5 percent to 12,089. Britain's FTSE 100 dropped 0.2 percent to 7,296. Wall...

Asian stocks rise on possible US-China talks amid tensions

Sep 19, 2018

SINGAPORE — Asian markets were mostly higher on Thursday after a report that the U.S. had proposed a new round of trade negotiations with China quelled fears that a dispute between the world's two largest economies was spiraling out of control. KEEPING SCORE: Japan's benchmark Nikkei 225 added 0.8 percent to 22,787.33, and the Kospi in South Korea rose 0.1 percent to 2,284.74. Hong Kong's Hang Seng index jumped 1.4 percent to 26,711.07. The Shanghai Composite index gained 0.2 percent to 2,662.54. But Australia's S&P/ASX 200 shed 0.6 percent to 6,141.00. Stocks were higher in Taiwan and Southeast Asia. WALL...

US lawmakers urge export restrictions targeting Xinjiang

Sep 19, 2018

BEIJING — Two U.S. lawmakers are urging the extension of tougher American export restrictions to prevent sales of equipment that could be used in China's massive security clampdown targeting the Xinjiang region's native Muslim population. Sen. Marco Rubio and Rep. Chris Smith want foreign entities, including businesses, research institutions, government and private organizations, and individuals seen as profiting from the clampdown added to a watch list, the two Republicans, among the staunchest critics of China in the U.S. Congress, said in a letter Wednesday to Commerce Secretary Wilbur Ross. "U.S. companies should not be assisting in the expansion of China's...

Asian stocks fall as China reacts to US tariffs

Sep 19, 2018

SINGAPORE — Asian shares fell on Wednesday as China delayed issuing licenses to American businesses hoping to operate in the country, as the threat of more trade tariffs from Washington loomed. The approach of Hurricane Florence on the East Coast and upcoming sanctions on Iran's energy industry lifted oil prices. Benchmark U.S crude surged past $70 a barrel. KEEPING SCORE: Japan's benchmark Nikkei 225 lost 0.4 percent to 22,571.76, and the Kospi in South Korea fell 0.2 percent to 2,279.70. Hong Kong's Hang Seng index was 0.2 percent lower at 26,372.02. The Shanghai Composite index fell 0.3 percent to 2,656.26....

Sign up now!